Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended		75 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
Revenues
Costs and expenses
Research and development	3,367	2,728	12,938
Selling, General and administrative	2,306	2,617	8,995
Total costs and expenses	5,673	5,345	21,933
Loss from operations	(5,673)	(5,345)	(21,933)
Other income and (expense)
Other income		244	1,147
Interest income		2	79
Amortization of deferred financing costs	(37)	(204)	(1,970)
Interest expense	(48)		(112)
Total other income and (expense)	(85)	42	(856)
Loss before income tax	(5,758)	(5,303)	(22,789)
Provision for income tax
Net loss	(5,758)	(5,303)	(22,789)
Loss attributable to common stockholders and loss per common share:
Net loss	(5,758)	(5,303)	(22,789)
Loss attributable to common stockholders	(5,758)	(10,382)	(28,156)
Weighted average shares outstanding, basic and diluted	28,004	22,230
Net loss per basic and diluted share	$ (0.21)	$ (0.47)
Series A Preferred Conversion
Loss attributable to common stockholders and loss per common share:
Deemed dividend		(4,301)	(4,301)
Series A Preferred Stock
Loss attributable to common stockholders and loss per common share:
Deemed dividend		(500)	(700)
Declared/Accrued Dividends - Series A Preferred Stock		$ (278)	$ (366)